Abstracted Scientific Content

Published in:
Volume 2 / Year 2013 / Issue 3

Biosimilar monoclonal antibodies – time for a regulatory rethink

Page: 154

The approval of biosimilars in the European Union (EU) is governed by the EU biosimilar framework released in 2004. But new arrivals on the biosimilar stage – monoclonal antibodies –… Read More »

Go Back Print